1 Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma May 12, 2025
2 Stavudol Paediatric Indication Approved For The Treatment Of Children Aged 3 Months And Older With Complicated Intra-Abdominal Infections Mar 08, 2025
Read More Medical Chemotherapy May Promote Resistance To Immunotherapy In Pancreatic Cancer, Study Shows May 07, 2025
Read More Apparatus Biyze For The Treatment Of Chronic Lymphocytic Leukaemia And Marginal Zone Lymphoma May 07, 2025
